EA201790985A1 - Новые соли (3r)-3-циклопентил-3-[4-(7h-пирроло[2,3-d]пиримидин-4-ил)пиразол-1-ил]пропаннитрила - Google Patents

Новые соли (3r)-3-циклопентил-3-[4-(7h-пирроло[2,3-d]пиримидин-4-ил)пиразол-1-ил]пропаннитрила

Info

Publication number
EA201790985A1
EA201790985A1 EA201790985A EA201790985A EA201790985A1 EA 201790985 A1 EA201790985 A1 EA 201790985A1 EA 201790985 A EA201790985 A EA 201790985A EA 201790985 A EA201790985 A EA 201790985A EA 201790985 A1 EA201790985 A1 EA 201790985A1
Authority
EA
Eurasian Patent Office
Prior art keywords
acid
pyrrolo
pyrazol
pyrimidin
propnanitril
Prior art date
Application number
EA201790985A
Other languages
English (en)
Russian (ru)
Inventor
Лудек Ридван
Виолетта Кишш
Гана Тозицкова
Марцела Ткадлецова
Ондрей Даммер
Лукас Крейцик
Original Assignee
Зентива, К.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зентива, К.С. filed Critical Зентива, К.С.
Publication of EA201790985A1 publication Critical patent/EA201790985A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA201790985A 2014-11-10 2015-11-05 Новые соли (3r)-3-циклопентил-3-[4-(7h-пирроло[2,3-d]пиримидин-4-ил)пиразол-1-ил]пропаннитрила EA201790985A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2014-773A CZ2014773A3 (cs) 2014-11-10 2014-11-10 Soli (3R)-3-cyklopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propannitrilu
PCT/CZ2015/000133 WO2016074650A1 (en) 2014-11-10 2015-11-05 Salts of (3r)-3-cyclopentyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile

Publications (1)

Publication Number Publication Date
EA201790985A1 true EA201790985A1 (ru) 2017-08-31

Family

ID=54608211

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790985A EA201790985A1 (ru) 2014-11-10 2015-11-05 Новые соли (3r)-3-циклопентил-3-[4-(7h-пирроло[2,3-d]пиримидин-4-ил)пиразол-1-ил]пропаннитрила

Country Status (4)

Country Link
EP (1) EP3218379A1 (cs)
CZ (1) CZ2014773A3 (cs)
EA (1) EA201790985A1 (cs)
WO (1) WO2016074650A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2015496A3 (cs) * 2015-07-14 2017-01-25 Zentiva, K.S. Krystalické formy solí (3R)-3-cyklopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propannitrilu a jejich příprava
CN110494435B (zh) 2017-06-07 2022-02-15 四川科伦博泰生物医药股份有限公司 氮杂环丁烷衍生物的固体形式及其制备方法和用途
CA3139457A1 (en) * 2021-11-19 2023-05-19 Apotex Inc. Novel salts of ruxolitinib and crystalline forms thereof
WO2024028193A1 (en) 2022-08-03 2024-02-08 Medichem, S.A. Stable oral pharmaceutical formulation containing ruxolitinib hemifumarate
WO2024099396A1 (zh) * 2022-11-11 2024-05-16 浙江奥翔药业股份有限公司 芦可替尼晶体及其药物组合物
EP4491175A1 (en) 2023-07-10 2025-01-15 Genepharm S.A. A solid oral composition of ruxolitinib

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2455382T (pt) 2005-12-13 2017-01-31 Incyte Holdings Corp Pirrolo[2,3-b]piridinas e pirrolo[2,3-b]pirimidinas substituídas por heteroarilo como inibidores de janus quinases
ES2903444T3 (es) 2007-06-13 2022-04-01 Incyte Holdings Corp Uso de sales del inhibidor de quinasas Janus (R)-3-(4-(7H-pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciclopentilpropanonitrilo
JOP20190230A1 (ar) 2009-01-15 2017-06-16 Incyte Corp طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
UA111588C2 (uk) * 2010-05-21 2016-05-25 Інсайт Холдінгс Корпорейшн Композиція інгібітора jak для місцевого застосування
NZ618367A (en) * 2011-06-14 2016-01-29 Novartis Ag Combination of panobinostat and ruxolitinib in the treatment of cancer such as a myeloproliferative neoplasm

Also Published As

Publication number Publication date
WO2016074650A1 (en) 2016-05-19
EP3218379A1 (en) 2017-09-20
CZ2014773A3 (cs) 2016-05-18

Similar Documents

Publication Publication Date Title
EA201790985A1 (ru) Новые соли (3r)-3-циклопентил-3-[4-(7h-пирроло[2,3-d]пиримидин-4-ил)пиразол-1-ил]пропаннитрила
IL256898B (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
LT3523301T (lt) Pakeistieji pirazolo[1,5-a]piridino junginiai kaip ret kinazės slopikliai
DK3523302T3 (da) Substituerede pyrazolo[1,5-A]pyridin-forbindelser som RET-kinase-inhibitorer
DK3160958T3 (da) Krystallinske salte af (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidin-4-carboxamid
LT3442980T (lt) Heterocikliniai junginiai, kaip ret kinazės inhibitoriai
EA201591420A1 (ru) Гетероарильные соединения и их применение
EA201590330A1 (ru) Соли и твердые формы (s)-3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и включающие их композиции и способы их применения
DK3433253T3 (da) Pyrimidinforbindelse som JAK-kinase-inhibitorer
MX376178B (es) Espirocicloheptanos como inhibidores de la cinasa rho (rock).
UY34763A (es) Inhibidores de la agregación plaquetaria
EP3807279A4 (en) Pharmaceutically acceptable salts of sepiapterin
DK3672965T3 (da) Pyramidinforbindelse som Jak-kinase-inhibitor
EA201600128A1 (ru) СОЛИ ПРОИЗВОДНЫХ 2-АМИНО-1-ГИДРОКСИЭТИЛ-8-ГИДРОКСИХИНОЛИН-2(1Н)-ОНА, ОБЛАДАЮЩИЕ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ И АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ
HUE051693T2 (hu) 5-Klór-N4-[2-(dimetilfoszforil)-fenil]-N2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)-piperidin-1-il] -pirimidin-2,4-diamin kristályos formái
DK3054927T3 (da) Formuleringer af (s)-3-(4-((4-morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidin-2,6-dion
MX2018003554A (es) Benzamidas sustituidas con isoxazolina y analogos como insecticidas.
HRP20181698T1 (hr) 2-amino-6-(difluormetil)-5,5-difluor-6-fenil-3,4,5,6-tetrahidropiridini kao inhibitori bace1
ZA201701131B (en) Novel 2,5-substituted pyrimidines as pde4 inhibitors
DK3287460T3 (da) Hemisulfatsalt af 5,10-methylen-(6r)-tetrahydrofolsyre
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
WO2014192030A3 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
UY34191A (es) ?N-(6-((2R,3S)-3,4-Dihidroxibutan-2-iloxi)-2-(4-fluorobenciltio)pirimidin-4-il)-3-metilazetidina-1-sulfonamida y sales farmacéuticamente aceptables de lamisma?.
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы